Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists
US-9487510-B2 · Nov 8, 2016 · US
Nitrobenzothiazole derivatives, preparation thereof and therapeutic applications thereof
US8993561B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8993561-B2 |
| Application number | US-201113988868-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 18, 2011 |
| Priority date | Nov 22, 2010 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates to the nitrobenzothiazole derivatives of general formula (I): and to the use thereof for treating tuberculosis.
First claim
Opening claim text (preview).
The invention claimed is: 1. A compound corresponding to formula (I): for which, R 1 represents: a (C 1 -C 4 )alkyl substituted with: one or more halogen atoms; an aryl substituted with one or more groups chosen, independently of one another, from an OH, (C 1 -C 3 )alkoxy, (C 3 -C 6 )heterocycloalkyl or (C 1 -C 3 )fluoroalkoxy group; a heteroaryl optionally substi…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
- C07D277/68Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8993561B2 cover?
- The invention relates to the nitrobenzothiazole derivatives of general formula (I): and to the use thereof for treating tuberculosis.
- Who is the assignee on this patent?
- Pellet Alain, Sanofi Sa
- What technology area does this patent fall under?
- Primary CPC classification C07D277/68. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).